MacroGenics
MGNX
#8310
Rank
NZ$0.52 B
Marketcap
NZ$8.28
Share price
1.95%
Change (1 day)
268.27%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.52 Billion

As of July 2026 MacroGenics has a market cap of NZ$0.52 Billion. This makes MacroGenics the world's 8310th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.52 B199.17%
2025NZ$0.17 B-51.08%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Jul 5th, 2026 the market cap of MacroGenics was reported to be:

NZ$0.52 Billion
by Nasdaq info icon info icon
NZ$0.52 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$243.58 B 46,198.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.902 T 361,475.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$354.85 B 67,349.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$286.40 B 54,339.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$562.31 B 106,783.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$208.60 B 39,550.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.95 B 271.47%๐Ÿ‡บ๐Ÿ‡ธ USA